CAT
Caterpillar Inc.
CAT has the edge over QRHC overall, supported by stronger modeled upside and lower modeled downside.
QRHC
Quest Resource Holding Corporation
QRHC offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
QRHC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Weak |
QRHC's revenue and cash flow are currently stable, but its profitability and balance sheet are under pressure.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
QRHC PE Valuation
QRHC has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over QRHC on the outlook, with more favorable revenue and profitability expectations.
QRHC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect QRHC's losses to shrink, with revenue holding steady.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over QRHC on earnings quality, reporting a profit while its opponent remains loss making.
QRHC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.78 | +$0.34 |
| Q2 2026 | -$0.82 | +$0.40 |
| Q1 2026 | -$0.34 | +$0.86 |
| Q4 2025 | -$0.73 | $0.00 |
| Q3 2025 | -$1.12 | -$0.74 |
| Q2 2025 | -$1.22 | -$0.90 |
| Q1 2025 | -$1.20 | -$0.91 |
| Q4 2024 | -$0.73 | -$0.37 |
QRHC is still losing money, but less than at its worst: $0.78 per share over the past year, against $1.22 at its worst in mid-2025.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over QRHC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over QRHC on profitability, with a higher operating margin.
QRHC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $63.8M | +0.7% |
| Q2 2026 | $64.1M | +7.6% |
| Q1 2026 | $61.7M | -9.8% |
| Q4 2025 | $58.9M | -16% |
| Q3 2025 | $63.3M | -13% |
| Q2 2025 | $59.5M | -19% |
| Q1 2025 | $68.4M | -5.8% |
| Q4 2024 | $70M | +0.9% |
QRHC's revenue has slid since its 2022 peak: $64M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.7% | +1 points |
| Q2 2026 | -16% | -16 points |
| Q1 2026 | 0.4% | +12 points |
| Q4 2025 | 0.9% | +11 points |
| Q3 2025 | 1.7% | +3 points |
| Q2 2025 | 0.6% | -1.8 points |
| Q1 2025 | -12% | -15 points |
| Q4 2024 | -10% | -9.9 points |
QRHC's operating margin was 2.7% last quarter, up 1 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
QRHC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$284K | -105% |
| Q2 2026 | $4.5M | +14% |
| Q1 2026 | $110K | +$1.3M |
| Q4 2025 | $1M | +$6.2M |
| Q3 2025 | $5.6M | +$6.2M |
| Q2 2025 | $3.9M | +$5.3M |
| Q1 2025 | -$1.2M | +$2.3M |
| Q4 2024 | -$5.2M | +$2.9M |
QRHC has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over QRHC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
QRHC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +140K shares |
| 1 year | +2.1% | +445K shares |
| 3 years | +7.1% | +1.4M shares |
| 5 years | +0.8% | +166K shares |
| Available history | +40% | +6.1M shares |
QRHC has 21M diluted shares, up 2.1% from a year ago.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
QRHC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 8.9x | High |
| Q4 2024 | 15.4x | High |
| Q3 2024 | 6.0x | High |
| Q2 2024 | 5.3x | High |
| Q1 2024 | 5.1x | High |
| Q4 2023 | 5.2x | High |
| Q3 2023 | 5.0x | High |
| Q2 2023 | 5.0x | High |
QRHC's net debt is about 8.9 years of its operating earnings (EBITDA), up from 5.1 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
QRHC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.8 | Neutral |
| Stochastic | 21.9 | Neutral |
QRHC's weekly RSI is 44 (neutral) and its Stochastic is 22 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
QRHC PE vs Industrials Sector
| Metric | QRHC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
QRHC has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over QRHC on trend strength, trading above more of its moving averages.
QRHC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.23 | 2.4% below |
| 20 week MA | $1.32 | 9.1% below |
| 50 week MA | $1.46 | 18% below |
| 100 week MA | $2.14 | 44% below |
| 200 week MA | $4.77 | 75% below |
QRHC is in a downtrend: it's below all five of its weekly moving averages, and 75% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over QRHC on returns for 2026, with the stronger performance.
QRHC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.24 | $2.01 | -10% |
| 2021 | $2.01 | $6.60 | +228% |
| 2022 | $6.60 | $6.12 | -7.3% |
| 2023 | $6.12 | $7.33 | +20% |
| 2024 | $7.33 | $6.06 | -17% |
| 2025 | $6.06 | $1.97 | -67% |
| 2026 YTD | $1.97 | $1.20 | -39% |
QRHC's yearly returns have swung widely, from +228% in 2021 to −67% in 2025. It's down 39% so far in 2026.